11 days ago
MBX
AnalystsEliana MerleEliana Merle's Stock Forecasts
AnalystsEliana Merle
Sectors:
Industries:
Analyst Ranking
Top 16%
#820 out of 5279 analysts
Average Return
+9.26%
Win Rate
48%51 out of 106
Risk vs Reward
Poor
Good
Eliana Merle's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Iveric Bio IncISEE | +237.97% | $11.01 | $37.21 | 2022-08-01 - 2023-05-03 | Strong Buy |
Cymabay Therapeutics IncCBAY | +213.84% | $1.59 | $4.99 | 2020-03-12 - 2021-03-12 | Strong Buy |
Kymera Therapeutics IncKYMR | +168.30% | $31.14 | $83.55 | 2025-05-12 - 2026-05-12 | Strong Buy |
Cymabay Therapeutics IncCBAY | +166.61% | $12.07 | $32.18 | 2023-08-13 - 2024-02-14 | Strong Buy |
Kadmon Holdings IncKDMN | +148.04% | $3.83 | $9.50 | 2021-05-20 - 2021-11-09 | Strong Buy |
Eliana Merle Analyst Color
Get additional color on Eliana Merle's coverage of popular stocks
12 days ago
ASND
2 months ago
INSM
2 months ago
IONS
3 months ago
BMRN
4 months ago
KYMR
4 months ago
VRTX
4 months ago
PTCT
8 months ago
BBIO
8 months ago
GOSS
10 months ago
ALNY
10 months ago
PROK
a year ago
BMRN
a year ago
ETNB
a year ago
AKRO
a year ago
RVMD
2 years ago
BMRN
2 years ago
MRNA
2 years ago
APLS
3 years ago
CBAY
3 years ago
APLS
4 years ago
MRNA
Eliana Merle's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Gossamer Bio IncGOSS | 6 | Strong Sell | $0.28 | +33.33% | Maintains | 4 days ago |
Mbx Biosciences IncMBX | 2 | Strong Buy | $70.00 | +119.78% | Maintains | 11 days ago |
Ascendis Pharma AASND | 4 | Strong Buy | $345.00 | +39.65% | Maintains | 12 days ago |
Vertex Pharmaceuticals IncVRTX | 3 | Strong Buy | $615.00 | +41.54% | Maintains | 17 days ago |
Moderna IncMRNA | 11 | Hold | $45.00 | -4.01% | Maintains | 19 days ago |
Regeneron Pharmaceuticals IncREGN | 2 | Strong Buy | $917.00 | +43.53% | Maintains | 23 days ago |
Ionis Pharmaceuticals IncIONS | 2 | Strong Buy | $115.00 | +51.76% | Maintains | 23 days ago |
Ultragenyx Pharmaceutical IncRARE | 1 | Strong Buy | $43.00 | +83.84% | Maintains | 24 days ago |
Insmed IncINSM | 2 | Strong Buy | $237.00 | +123.08% | Maintains | 2 months ago |
Apellis Pharmaceuticals IncAPLS | 9 | Hold | $41.00 | -0.07% | Maintains | 2 months ago |
Uniqure NvQURE | 6 | Hold | $25.00 | +3.35% | Maintains | 2 months ago |
Biomarin Pharmaceutical IncBMRN | 4 | Strong Buy | $105.00 | +94.12% | Maintains | 3 months ago |
Tpg IncTPG | 2 | Strong Buy | $56.00 | +34.55% | Maintains | 3 months ago |
Kymera Therapeutics IncKYMR | 4 | Strong Buy | $133.00 | +68.59% | Maintains | 4 months ago |
Tyra Biosciences IncTYRA | 2 | Strong Buy | $59.00 | +81.71% | Initiates Coverage On | 4 months ago |
Sagimet Biosciences IncSGMT | 2 | Hold | $8.00 | +12.83% | Initiates Coverage On | 4 months ago |
Ptc Therapeutics IncPTCT | 1 | Strong Buy | $119.00 | +72.94% | Upgrades | 4 months ago |
Madrigal Pharmaceuticals IncMDGL | 6 | Strong Buy | $964.00 | +86.37% | Initiates Coverage On | 4 months ago |
Inventiva SaIVA | 2 | Strong Buy | $18.00 | +255.03% | Initiates Coverage On | 4 months ago |
4d Molecular Therapeutics IncFDMT | 1 | Strong Buy | $33.00 | +283.72% | Initiates Coverage On | 4 months ago |
Bridgebio Pharma IncBBIO | 5 | Strong Buy | $80.00 | +15.74% | Initiates Coverage On | 4 months ago |
Alnylam Pharmaceuticals IncALNY | 4 | Strong Buy | $527.00 | +77.17% | Initiates Coverage On | 4 months ago |
Altimmune IncALT | 2 | Strong Buy | $24.00 | +727.59% | Maintains | 9 months ago |
Rapt Therapeutics IncRAPT | 4 | Hold | $9.00 | -84.49% | Maintains | 9 months ago |
Anaptysbio IncANAB | 5 | Hold | $20.00 | -66.50% | Maintains | 9 months ago |
Sarepta Therapeutics IncSRPT | 1 | Hold | $12.00 | -28.57% | Downgrades | 10 months ago |
Prokidney CorpPROK | 1 | Strong Buy | $8.00 | +357.14% | Maintains | 10 months ago |
Curevac NvCVAC | 3 | Hold | $5.50 | +18.03% | Downgrades | a year ago |
Arvinas IncARVN | 5 | Strong Buy | $21.00 | N/A | Maintains | a year ago |
89bio IncETNB | 3 | Strong Buy | $38.00 | N/A | Maintains | a year ago |
Akero Therapeutics IncAKRO | 4 | Strong Buy | $109.00 | N/A | Maintains | a year ago |
Zentalis Pharmaceuticals IncZNTL | 4 | Hold | $2.20 | N/A | Maintains | a year ago |
Revolution Medicines IncRVMD | 2 | Strong Buy | $71.00 | N/A | Maintains | a year ago |
Biontech SeBNTX | 4 | Hold | $131.00 | N/A | Maintains | 2 years ago |
Kodiak Sciences IncKOD | 3 | Hold | $5.00 | N/A | Maintains | 2 years ago |
Terns Pharmaceuticals IncTERN | 2 | Strong Buy | $18.00 | N/A | Maintains | 2 years ago |
Cymabay Therapeutics IncCBAY | 5 | Hold | $32.50 | N/A | Downgrades | 2 years ago |
Iveric Bio IncISEE | 2 | Hold | $40.00 | N/A | Downgrades | 3 years ago |
Monte Rosa Therapeutics IncGLUE | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | 4 years ago |
Regenxbio IncRGNX | 1 | Strong Buy | $47.00 | N/A | Maintains | 4 years ago |
Kadmon Holdings IncKDMN | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | 5 years ago |
Amicus Therapeutics IncFOLD | 2 | Strong Buy | $16.00 | N/A | Initiates Coverage On | 5 years ago |
Lakefront Biotherapeutics NvLKFT | 2 | Hold | $134.00 | N/A | Maintains | 6 years ago |
Alexion Pharmaceuticals IncALXN | 1 | Hold | $121.00 | N/A | Initiates Coverage On | 6 years ago |
Cartesian Therapeutics IncRNAC | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 6 years ago |
Tesaro IncTSRO | 1 | Strong Buy | $68.00 | N/A | Maintains | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.